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This research paper is aimed at evaluating the predictive role of a default panel of oxidative stress (OS) biomarkers for the early
identiﬁcation of infants at high risk of HIE and their validation through the correlation with MRI ﬁndings. A multicenter
prospective observational study was performed between March 2012 and April 2015 in two European tertiary NICUs. Eighty-
four term infants at risk for HIE (pH< 7, BE<−13mmol/L, and 5′ Apgar< 5) were enrolled. Three were excluded for
chromosomal abnormalities and one due to lack of blood samples. The ﬁnal population was divided according to the severity of
perinatal hypoxia into 2 groups: mild/moderate HIE and severe HIE. Advanced oxidation protein products (AOPP), non-
protein-bound iron (NPBI), and F2-isoprostanes (F2-IsoPs) were measured in blood samples at P1 (4–6 hours), P2 (24–72
hours), and P3 (5 days), in both groups. MRIs were scored for the severity of brain injury, using a modiﬁed Barkovich score.
The mean GA was 39.8 weeks (SD 1.4) and the mean birth weight 3538 grams (SD 660); 37 were females and 43 males.
Signiﬁcantly lower 5′ Apgar score, pH, and BE and higher Thompson score were found in group II compared to group I at
birth. Group II showed signiﬁcantly higher AOPP and NPBI levels than group I (mean (SD) AOPP: 15.7 (15.5) versus 34.1
(39.2), p = 0 033; NPBI 1.1 (2.5) versus 3.9 (4.4), p = 0 013) soon after birth (P1). No diﬀerences were observed in OS biomarker
levels between the two groups at P2 and P3. A regression model, including adjustment for hypothermia treatment, gender, and
time after birth, showed that AOPP levels and male gender were both risk factors for higher brain damage scores (AOPP: OR
3.6, 95% CI (1.1–12.2) and gender: OR 5.6, 95% CI (1.2–25.7), resp.). Newborns with severe asphyxia showed higher OS than
those with mild asphyxia at birth. AOPP are signiﬁcantly associated with the severity of brain injury assessed by MRI, especially
in males.
1. Introduction
Birth asphyxia is largely recognized as the most frequent
cause of acute interruption of oxygen to the fetus and the
most common cause of brain damage [1]. Currently, despite
the advances oﬀered by therapeutic hypothermia in terms of
neuroprotection, the improvements on long-term neurologi-
cal outcome remain modest [2–4]. Twenty to ﬁfty percent of
asphyxiated infants who develop HIE die in the neonatal
period, and about twenty-ﬁve percent of survivors will
develop neurological disabilities, such as cerebral palsy, cog-
nitive deﬁcits, learning disorders, sensory disruption, and
neuropsychiatric problems [5]. Therefore, one of the most
important goals in the approach to patients with HIE
remains actually to determine the exact period in which the
eﬀects of potential damaging factors occur [1, 2, 5, 6]. Several
methods are now available for detecting the type and timing
of brain damage: conventional prenatal tests, such as fetal
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cardiotocography; ultrasound; Doppler and amniotic ﬂuid
examination neuroimaging; aEEG; NIRS; and determination
of numerous currently available biomarkers. Each provides
information about diﬀerent expressions of brain injury and
has some limitations [1, 7]. MRI is the gold standard for
the early evaluation of brain injury after HIE, including not
only traditional neuroimaging methods but also advanced
imaging techniques (DWI, 1H-MRS, and ASL) [8–11]. In this
context, the use of speciﬁc biomarkers that will increase
within the ﬁrst hours of life in hypoxic-ischemic neonates
may help in the early diagnosis of HIE and promptly identify
neonates who may qualify for neuroprotection. Oxidative
stress is involved in the mechanisms of hypoxic-ischemic
and inﬂammatory brain injury, although the relationship
between brain damage and OS is very complex and not
entirely clear [12–15]. The pathophysiological process that
leads to the development of brain lesions is in fact character-
ized by the combination of several mechanisms, either
exogenous or endogenous (hypoxia, ischemia, ischemia-
reperfusion, hyperoxia, inﬂammation, and mitochondrial
damage), whose eﬀect on cell biology and on oxidative
metabolism varies according to the severity and duration of
the insult [16]. Furthermore, certain brain areas are particu-
larly rich in iron, released by cells damaged during hypoxia,
which may catalyze, through the Fenton reaction, the forma-
tion of hydroxyl radicals and nitroperoxide and so make the
central nervous system more susceptible to the attack of the
reactive species [17]. In addition, the brain of a full-term
baby, being rich in polyunsaturated fatty acids and low in
antioxidants, is particularly vulnerable to the free radical
attack [18]. Increased oxidative stress in hypoxic fetuses
and neonates has been detected by assaying several bio-
markers: products of lipid peroxidation in expired air, serum
malondialdehyde reaction, serum isoprostanes, serum total
hydroperoxides, advanced oxidative protein products, and
increased NPBI in serum [18–20]. Despite extensive research
in the ﬁeld over the last few years, no such biomarker has
been validated in clinical practice so far. So the aim of our
study was to evaluate the predictive role of a default panel
of OS biomarkers for the early identiﬁcation of infants at
high risk of hypoxic-ischemic brain injury and their valida-
tion through the correlation with MRI.
2. Methods
2.1. Subjects. Eighty-four term subjects, born between March
2012 and April 2015, with clinical and biochemical signs of
HIE, admitted to two European tertiary NICUs as part of a
multicenter prospective observational study, were consecu-
tively enrolled. The inclusion criteria were the presence of
perinatal asphyxia deﬁned as at least three of the following
criteria: (1) late decelerations on fetal monitoring or meco-
nium staining; (2) delayed onset of respiration, resuscitation,
or ventilation of at least 10min; (3) Apgar scores< 5 at 5
minutes; (4) arterial cord blood pH< 7.1 with a base
deﬁcit> 16mmol/L or serum lactate> 10mmol/L; (5) multi-
organ failure, followed by symptoms of encephalopathy, such
as altered alertness, abnormal tone, feeding diﬃculties, or
seizures demonstrated by a Thompson score≥ 7 and/or
abnormal brain activity by aEEG; and (6) hypothermia treat-
ment started within 6 h after birth [4, 7, 21]. HIE was classi-
ﬁed as mild (grade I), moderate (grade II), or severe (grade
III) according to the criteria described by H.B. Sarnat and
M.S. Sarnat [22]. The clinical evaluation of encephalopathy
took place 24 and 48 hours after birth. Babies with major
congenital abnormalities, brain malformations, central ner-
vous system infections, and inborn errors of metabolism
were excluded. As soon as possible after admission to the
Neonatal Intensive Care, all enrolled children were subjected
to the routine checks, including a blood gas analysis, and
were started on aEEG and NIRS monitoring. Hypothermia
was initiated within 6 h after birth, lasted for 72 h, and was
aimed for a rectally measured body temperature of 33.5°C.
Seventy-two hours after starting hypothermia, subsequent
rewarming at 0.5°C per hour was performed. Body tempera-
ture (°C), heart rate, arterial blood pressure, and arterial oxy-
gen saturation (SaO2) were monitored simultaneously with
NIRS and aEEG parameters, and their recorded values were
all stored on a personal computer for oﬀ-line analysis (soft-
ware: Poly 5, Inspektor Research Systems, Amsterdam, the
Netherlands). All clinical and demographic data were col-
lected from the hospital records. The study was approved
by the medical ethical review board of the two respective uni-
versity hospitals, with written informed parental consent,
obtained according to the Declaration of Helsinki.
2.2. Oxidative Stress Methodology. Advanced oxidation pro-
tein products (AOPP), F2-isoprostanes (F2-IsoPs), and
non-protein-bound iron (NPBI) were all measured in blood
samples, taken during routine tests and only after obtaining
Table 1: Scoring system for brain injury seen on MRI scans.
Score Description
Basal ganglia and thalamus
0 Normal
1 Abnormal signal in the thalamus
2
Abnormal signal in the thalamus and
lentiform nucleus
3
Abnormal signal in the thalamus,
lentiform nucleus, and perirolandic cortex
4 More extensive involvement
Watershed areas
0 Normal
1 Single focal infarction
2
Abnormal signal in the anterior or
posterior watershed white matter
3
Abnormal signal in the anterior or
posterior watershed cortex and white matter
4
Abnormal signal in both anterior and
posterior watershed zones
5 More extensive cortical involvement
Posterior limb of the internal capsule
0 Myelination present
1 Myelination present but impaired
2 Myelination absent
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the parents’written consent, at P1 (4–6h after birth), P2 (24–
72 h after birth), and P3 (5 days after birth). For each blood
sample, 2.5ml of blood was collected: 1.3ml in EDTA (ethyl-
enediaminetetraacetic acid) tubes and 1.2ml in two test tubes
(0.6ml each) containing heparin. Each of these samples was
immediately centrifuged (Prog 1, RTM 1500, T 4°C,
10min) to remove cells and obtain the supernatant, which
was then separated into ﬁve diﬀerent microtest tubes, one
of which contains BHT (butylated hydroxytoluene), and
stored at −80°C. The obtained samples were subsequently
analyzed to measure OS biomarkers. AOPP and F2-IsoPs
were detected as markers of protein and lipid OS-induced
injury, respectively, by the method of Witko-Sarsat et al.,
using spectrophotometry on a microplate reader, and iso-
prostanes were detected according to the LC-MS/MS meth-
odology described by Casetta et al. [23, 24]. The AOPP
were calibrated with chloramine-T solutions that absorb at
340nm in the presence of potassium iodide. In test wells,
200μL of plasma diluted at 1 : 5 in phosphate-buﬀered saline
solution (PBS) was distributed on a 96-well microtiter plate,
and 20μL of acetic acid was added. In standard wells, 10
microliters of 1.16M potassium iodide was added to 200μL
of chloramine-T solutions followed by 20μL of acetic acid.
The absorbance of the reaction mixture was immediately
read at 340nm on the microplate reader against a blank con-
taining 200μL of PBS, 10μL of potassium iodide, and 20μL
of acetic acid. Because the absorbance of chloramine-T at
340nm is linear up to 100μmol/L, AOPP were expressed as
μmol/L of chloramine-T equivalents. NPBI was detected as
a marker of OS potential risk, by HPLC using the method
described by Paﬀetti et al. [25].
2.3. MRI Scoring. Depending on their clinical condition,
infants underwent MRI at a postnatal age of 5± 3 days. Intra-
venous sedation was continued during the MR examination
for infants who had an intravenous line placed; others
received an oral sedation with chloral hydrate (50–60mg/
kg). Infants were wrapped into a vacuum cushion to mini-
mize motion, and earmuﬀs (EM’s 4 Kids, Everton Park, Aus-
tralia) were used for hearing protection. Respiratory rate
(Philips Medical Systems, Best, the Netherlands), heart rate,
and transcutaneous oxygen saturation (Nonin Pulse Oxyme-
try, Nonin Medical, Plymouth, MN) were monitored during
MR imaging, and a neonatologist was present throughout the
examination. The severity of brain injury was assessed by
using conventional axial T1- and T2-weighted spin-echo
sequences, DWI, and ADC maps. MRIs were reviewed retro-
spectively by two expert investigators (LV and FG) who were
blinded to the infant’s outcome. Injury was scored for the
basal ganglia and thalami in combination with cortical
involvement, the watershed areas, and the posterior limb of
the internal capsule, by using the modiﬁed Barkovich score
(Table 1), ranging from 0 (no damage) to 11 (massive brain
damage), described previously as being predictive for neuro-
developmental outcomes after HIE [21, 22].
2.4. Statistical Analysis. Descriptive and inferential analyses
were performed using the SPSS v23 for Windows statisti-
cal package (SPSS Inc., Chicago, IL, USA). Data are pre-
sented as mean and SD or median and interquartile
range (IR) for descriptive analysis of continuous variables,
whereas for categorical variables, the absolute frequencies
are reported. A logarithmic transformation was performed
for the variables that were not parametrically distributed.
The independent t-test and the Mann–Whitney U test
were used, where appropriate, to make comparisons
regarding all patient characteristics, OS biomarker mea-
surements at each time point, and gender diﬀerences.
Pearson correlation and scatter dot plot were used, respec-
tively, to examine and visualize the relationship between
OS biomarkers and MRI score for each period of interest.
A longitudinal model was built to analyze the association
between OS biomarkers and the brain damage measured
through the Barkovich score. Gender, treatment with
hypothermia, and time of life (corresponding to the
selected periods of blood sample collection) were intro-
duced into the model as confounding factors. ROC curve
was performed to ﬁnd an MRI score cut-oﬀ able to dis-
criminate between newborns with a major risk to die
and newborns with a good outcome. A multivariable logis-
tic regression model was then built to verify if the
increased level of OS biomarkers may be a risk factor for
Table 2: Clinical and biochemical signs of hypoxic-ischemic encephalopathy reported by groups.
Mild-to-moderate HIE group (n = 21) Severe HIE group (n = 59) p
Median Apgar 1min (IR) 2 (1–4) 1 (0–2) NS
Median Apgar 5min (IR) 4 (4-5) 3 (1–5) 0.002
Median Apgar 10min (IR) 7 (5–7) 6 (3–7) 0.011
Mean umbilical pH (SD) 7.0 (0.1) 7.0 (0.2) NS
Mean umbilical BE (mmol/L) (SD) −13.7 (6.2) −13.8 (8.3) NS
Mean pH at admission (15min–6 h of life) (SD) 7.1 (0.1) 6.9 (0.2) 0.043
Mean BE at admission (15min–6 h of life, mmol/L) (SD) −11.1 (6.7) −16.3 (7.7) 0.013
Mean lactate at admission (15min–6 h of life, mmol/L) (SD) 13.6 (5.2) 15.4 (7.8) NS
Mean PNA at MRI (days) (SD) 3 (2) 6 (4) NS
Median Thompson score (1 h of life) (IR) 4 (2–5) 9 (7–13) 0.000
Seizures n (%) 2 (9) 27 (54) 0.001
IR: interquartile range; SD: standard deviation. NS: not statistically signiﬁcant.
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neurological damage, measured using MRI. The MRI score
was introduced into the model as a dichotomic dependent
variable, using the ROC curve cut-oﬀ; gender, treatment
with hypothermia, and time of life were also considered
in the model as covariates together with each biomarker.
A p value < 0.05 was considered statistically signiﬁcant.
3. Results
Out of eighty-four enrolled patients, three were excluded for
chromosomal abnormalities and one due to lack of blood
samples. So the ﬁnal population consisted of eighty infants
with a mean gestational age of 39.8 weeks (SD 1.4) and a
mean birth weight of 3538 grams (SD 660); 37 were females
and 43 males. Twenty newborns at risk for HIE were
classiﬁed with mild (Sarnat I), 1 was classiﬁed with moderate
(Sarnat II), and 59 were classiﬁed with severe signs of HIE
(Sarnat III). The mild group was not considered for hypo-
thermia, while the severe group was considered eligible for
hypothermia. The moderate one was eligible for hypothermia
treatment; however, he was born in a peripheral hospital and
arrived too late (thus later than 6 hours after birth) to
perform it. Newborns were then divided according to the
severity of HIE into two groups: mild/moderate HIE (not eli-
gible/late for the treatment with hypothermia, n = 21) and
severe HIE (eligible for hypothermia treatment, n = 59).
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Figure 1: Relationship between OS biomarkers and the grade of perinatal hypoxia reported over time. Comparison of AOPP levels (μmol/L)
(a), NPBI levels (μmol/L) (b), and IsoP levels (pg/mL) (c), between each group in the ﬁrst 5 days of life. AOPP: advanced oxidation protein
products; NPBI: non-protein-bound iron; ◦: outliers. ∗p < 0 05.
4 Oxidative Medicine and Cellular Longevity
Clinical and biochemical signs of HIE for each group are
reported in Table 2. None of the infants of the mild group
showed signs of progression to moderate or severe HIE.
3.1. Relationship between OS Biomarkers and the Grade of
HIE—Comparison between the Two Groups over Time. The
mild/moderate HIE group showed signiﬁcantly lower AOPP
and NPBI levels than the severe HIE group at time P1 (AOPP
median (IR): 9.4 (13.6) versus 18.6 (19.5) μmol/L, p = 0 033
and NPBI median (IR): 0.0 (3.8) versus 2.4 (3.3) μmol/L,
p = 0 013, resp.) (Figures 1(a) and 1(b)). No diﬀerences
were observed in AOPP and NPBI levels in P2 and P3
(Figures 1(a) and 1(b)). No other diﬀerences were observed
in F2-IsoP levels between the two groups (Figure 1(c)).
The severe HIE group showed also signiﬁcantly lower
AOPP levels in males than in females at time P1 (AOPP
median (IR): 14.8 (10) versus 27.6 (50.7) μmol/L, p = 0 013;
Figure 2). No diﬀerences in AOPP levels were observed
between males and females in P2 and P3. No diﬀerences in
NPBI and IsoP levels were found between males and females
at any time.
3.2. MRI Score and Survival. Out of eighty enrolled patients,
ﬁfty-six (70%) underwent MRI at a postnatal age of 5± 3
days: respectively, 5 of 21 (23%) of the mild/moderate
asphyxia group and 51 of 59 (86%) of the severe asphyxia
group, according to their clinical condition. Each MRI score
and the corresponding outcome are reported in Table 3.
The ROC curve discriminating newborns with a major
risk to die versus newborns surviving without impairments
was set at an MRI score value of 4.5 (100% sensitivity,
97.7% speciﬁcity, p = 0 0001; Figure 3). The MRI score rang-
ing from 0 to 4.5 showed 100% sensitivity and 100% of true
negative fraction for a good neurological outcome. Con-
versely, 100% of poor neurodevelopmental outcome was
observed for MRI score values> 8.5. The MRI score plotted
curve indicated 4.5 as the best predictive threshold with a
sensitivity of 100% (95% CI 63.06–100) and a speciﬁcity of
97.7% (95% CI 88.2–99.9).
3.3. Relationship between OS Biomarkers and the Severity of
Brain Injury Assessed with MRI. The longitudinal multivari-
able model, adjusted for confounding factors, showed a
signiﬁcant independent association between AOPP levels
(ln transformation) and MRI scores (p = 0 006, B = 1 301,
CI 95% 0.38–2.22; Figure 4(a)), indicating that the increase
of protein peroxidation levels during the ﬁrst ﬁve days of life
is associated with severe brain damage. In particular, males
showed an increased risk of oxidative neurological damage,
as comes to light from the signiﬁcant correlation between
AOPP and brain damage in males (p = 0 005, r = 0 465;
Figure 4(b)). Using the ROC curve cut-oﬀ, a multivariable
logistic regression model was performed, taking the MRI
score as a dichotomic dependent variable. The last model
conﬁrmed that AOPP levels and male gender were both risk
factors for more severe brain damage (AOPP: OR=3.6, 95%
CI 1.1–12.2 and gender: OR=5.6, 95% CI 1.2–25.7, resp.). In
detail, the increase of an AOPP logarithmic scale of 1
increases 3.6 times the risk of brain damage. As for the other
two biomarkers, both regression models showed a negative
association between the levels of NPBI (ln) and MRI score
(linear model: B = −0 94, 95% CI −1.69 to −0.18; logistic
model: OR=0.20, 95% CI 0.06–0.71). No statistically signiﬁ-
cant association was found between the plasma levels of IsoPs
and MRI score.
4. Discussion
Early objective diagnosis of brain injury is important for
prognostication and decision-making in term newborns with
HIE. Our study illustrates that infants who have suﬀered
from severe birth asphyxia show increased OS levels com-
pared with those who have had mild or moderate asphyxia.
In particular, the increase of OS levels in the perinatal period
was highlighted by a higher accumulation of plasmatic levels
of AOPP and the index of membrane protein oxidative dam-
age. The high levels of AOPP were signiﬁcantly associated
with an increase in brain damage, quantiﬁed with MRI. In
our study, males, despite lower levels of OS at birth, were at
the greatest risk of developing brain injury, showing an
increased susceptibility to oxidative stress damage. The new-
born brain is particularly susceptible to oxidative damage,
both for the reduced antioxidant capacity and for the high
consumption of oxygen and the high concentration of lipids
and chemically reactive species, such as free iron [26, 27].
Free radicals, which are continuously produced in the course
of the common cellular metabolic processes, greatly increase,
especially at the cerebral level, after a hypoxic-ischemic event.
Asphyxia and acidosis result in fact in the release of free iron
in plasma, and free iron itself is responsible for further free
radical formation, such as isoprostanes and AOPP. The neo-
natal brain, being particularly rich in polyunsaturated fatty
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acids, is particularly vulnerable to lipid peroxidation during
asphyxia, making the immature myelin particularly suscepti-
ble to free radical attack [28]. The OS derived from the over-
production of free radicals dominates the lack of antioxidant
mechanisms, including reduced activity of superoxide dis-
mutase, catalase, and glutathione peroxidase (GPX), and it
was thus involved in the pathogenesis of hypoxic-ischemic
injury [29–31]. The increased production of GPX detected
in the cerebrospinal ﬂuid of neonates with HIE by Vasiljević
et al. suggests that this is an active mechanism of response to
oxidative stress induced by hypoxia-ischemia. Moreover, the
same authors found that increased GPX activity correlates
with the severity of the insult and hypoxic brain damage
[31]. After HIE, the increase in OS occurs especially during
the reperfusion and reoxygenation phase. In this phase, the
free iron release and the activation of some prooxidant
enzymes (such as the nitric oxide synthese, cyclooxygenase,
lipooxygenase, and xanthine oxidase) determine a chain
reaction, culminating in the production of free radicals, such
as the highly toxic peroxynitrite, which cause cell damage
through the peroxidation of membrane lipids and damage
to DNA and proteins [32, 33]. The cascade activation of all
these mechanisms leads to endothelial damage, with
increased capillary permeability and therefore cytotoxic
edema; soon after, the activation of caspases 3 and 9 causes
the activation of apoptotic mechanisms [28, 29, 32, 34–36].
The higher the plasma AOPP, end products of protein perox-
idation, and thus index of free radical damage, the more
severe was the perinatal hypoxia-ischemia, conﬁrming what
has so far reported in the literature and emphasizing how
proteins are the ﬁrst target of toxic action of free radicals.
An increase of carbonyl groups and expression of protein
oxidation has been widely demonstrated and observed from
the earliest 3 hours after the advent of hypoxia-ischemia
[18, 37, 38]. The altered protein molecules act as a trap for
free radicals, which further start chain reactions, worsening
the damage. Often, this type of reactions is catalyzed by tran-
sition metals such as iron and copper, which enter the Fenton
reaction [39]. Iron, in particular, is released from ferritin,
although it may also derive from transferrin, hemoglobin,
myoglobin, lactoferrin, and cytochromes. During hypoxia
and subsequent reoxygenation, iron is moved from storage
Table 3: MRI scores and outcome reported by groups.
Group MRI score Outcome
Mild/Moderate HIE
1 7 Survived
2 1 Survived
3 1 Survived
4 0 Survived
5 0 Survived
Severe HIE
1 11 Died
2 11 Died
3 10 Died
4 7 Survived
5 6 Died
6 5 Died
7 5 Died
8 5 Died
9 5 Died
10 5 Died
11 4 Survived
12 4 Survived
13 3 Survived
14 3 Survived
15 1 Survived
16 1 Survived
17 1 Survived
18 1 Survived
19 1 Survived
20 1 Survived
21 1 Survived
22 1 Survived
23 1 Survived
24 1 Survived
25 1 Survived
26 0 Survived
27 0 Survived
28 0 Survived
29 0 Survived
30 0 Survived
31 0 Survived
32 0 Survived
33 0 Survived
34 0 Survived
35 0 Survived
36 0 Survived
37 0 Survived
38 0 Survived
39 0 Survived
40 0 Survived
41 0 Survived
Table 3: Continued.
Group MRI score Outcome
42 0 Survived
43 0 Survived
44 0 Survived
45 0 Survived
46 0 Survived
47 0 Survived
48 0 Survived
49 0 Survived
50 0 Survived
51 0 Survived
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sites and converted to a form detectable in the plasma and
extracellular space, so called “free iron” or NPBI. The
increase in NPBI levels exposes proteins and membrane
lipids to the attack of free radicals and thus to oxidative dam-
age [37, 40]. In the literature, several studies have reported
the role of free iron in the post anoxic oxidative damage. Cic-
coli et al. have shown that erythrocytes of hypoxic infants
released more iron than those of normoxic adults [41]. Buo-
nocore et al. reported that the plasma level of NPBI is highly
predictive of intrauterine suﬀering and brain damage [42]. In
our study, NPBI levels were signiﬁcantly higher in infants
with severe perinatal asphyxia in the ﬁrst six hours of life,
while free iron plasma levels in this group of infants showed
a downward trend, probably linked to the eﬀect of hypother-
mia. Numerous studies in fact have shown that therapeutic
hypothermia is eﬀective not only in reducing brain damage
and improving long-term outcomes but also in reducing
levels of reactive oxygen species responsible for oxidative
damage [38, 43]. As overproduction of free iron is known
to be a consequence of hypoxia-induced acidosis, we hypoth-
esized that the recovery of cellular metabolism during hypo-
thermia will lead to a reduction of triggers of free iron release;
meanwhile, AOPP and isoprostanes and expression of oxida-
tive cellular damage persist to be increased in plasma.
Despite the signiﬁcant diﬀerence highlighted in the levels
of AOPP between boys and girls at birth, our study conﬁrms
what is already well known that there is a higher male suscep-
tibility to brain oxidative damage. A recent European analysis
on 4500 children with cerebral palsy revealed in fact that inci-
dence of cerebral palsy is 30 times higher in males than in
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females [44]. These gender diﬀerences in the immature brain
seem to be related to intrinsic chromosomal and hormonal
diﬀerences. The protective role of estrogen against OS and
thus the fact that most males are susceptible to oxidative
damage have been reported by numerous studies [45–47].
Giordano et al. demonstrated in an animal model that estro-
gens modulate the cerebral expression of some antioxidant
enzymes (paraoxonase 1 and 2 (PON1 and PON2)), increas-
ing in this way the resistance of female neurons to oxidative
damage [46]. Furthermore, although the neuroprotective
eﬀect of estrogen is well known, the absence of the protective
eﬀect of estradiol in some cells of PON2-knockout mice
(PON2−/−) suggests that other mechanisms of neuroprotec-
tion related to female hormones may come into action
against free radical damage [45, 48]. The presence of diﬀer-
ences in the OS levels between males and females and their
relationships with the hormonal status have also been
emphasized by another study by Minghetti et al, in which
males have a higher lipid peroxidation and reduced antioxi-
dant capacity than females, contributing to the concept of
male disadvantage in respect of the damage caused by free
radicals [47]. Despite the advent of new studies and research
projects, the exact mechanisms producing these gender dif-
ferences are still largely unknown.
The role of oxidative stress in newborn morbidity with
respect to the increased risk of free radical damage in these
babies is growing. However, challenges remain in the early
identiﬁcation of infants at risk for neonatal encephalopathy,
determination of timing and extent of hypoxic-ischemic
brain injury, and optimal management and treatment [49].
Despite ongoing limits such as the need of a speciﬁc kit and
speciﬁc instruments to measure oxidative stress biomarkers
consequently associated with the need of an expert laboratory
team and the high cost, making the process of reaching the
goal slower, researchers are currently working to develop a
biomarker panel, which can become useful to the clinicians
as a point of care.
Literature on brain imaging of asphyxiated newborns
typically uses MRI standard imaging techniques, per-
formed following hypothermia at the end of the ﬁrst week
of life, to deﬁne the presence and extent of brain injury in
these newborns and to provide a prognosis for subsequent
neurological impairment [50]. DWI allows recognition of
structural brain abnormalities during the ﬁrst week, which
only become clearly visible on conventional imaging by
days 7–10 of life [51, 52].
The presence of an association between biomarkers of
oxidative stress, measured in the ﬁrst hours of life, and
brain damage successfully evaluated through neuroimaging
emphasizes the possibility of early identiﬁcation of new-
borns at greater risk of brain damage and also underlines
the validity of the AOPP, as products of OS damage in
the plasma and therefore as biomarkers of neuronal
damage. Knowing also that, after a hypoxic-ischemic
insult, cellular damage on energy substrates continues to
evolve over the ﬁrst 12–48 hours, we suggest that the
introduction of new neuroprotective strategies and antiox-
idants in such an early stage of life could change the long-
term outcome of these infants.
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